Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-635
Closed -$31.8K 4285
2025
Q4
$31.8K Sell
635
-75,612
-99% -$3.64M ﹤0.01% 1860
2025
Q3
$3.74M Buy
76,247
+76,178
+110,403% +$3.9M 0.05% 302
2025
Q2
$3.57K Sell
69
-6
-8% -$276 ﹤0.01% 2360
2025
Q1
$3.51K Sell
75
-356
-83% -$18.4K ﹤0.01% 1907
2024
Q4
$22.1K Sell
431
-4
-0.9% -$207 ﹤0.01% 1173
2024
Q3
$19.3K Buy
435
+9
+2% +$394 ﹤0.01% 1100
2024
Q2
$17.1K Buy
+426
New +$16.1K ﹤0.01% 1030
2023
Q4
Sell
-228
Closed -$6.35K 1417
2023
Q3
$6.35K Buy
228
+16
+8% +$501 ﹤0.01% 825
2023
Q2
$6.41K Buy
212
+112
+112% +$3.27K ﹤0.01% 810
2023
Q1
$3.08K Sell
100
-32
-24% -$1.22K ﹤0.01% 943
2022
Q4
$4.96K Sell
132
-34
-20% -$1.35K ﹤0.01% 799
2022
Q3
$6K Buy
166
+39
+31% +$1.55K ﹤0.01% 764
2022
Q2
$5K Buy
127
+109
+606% +$4.51K ﹤0.01% 797
2022
Q1
$1K Sell
18
-31
-63% -$1.57K ﹤0.01% 1093
2021
Q4
$2K Buy
49
+31
+172% +$1.47K ﹤0.01% 928
2021
Q3
$1K Buy
+18
New +$761 ﹤0.01% 943

Other funds holding SNV

Arax Advisory Partners's SNV Position: Q1 2026 in Review

Arax Advisory Partners sold out of Synovus (SNV) in Q1 2026, closing a stake of 635 shares — an estimated $31.8K sold.

Arax Advisory Partners first reported a position in SNV in Q3 2021 and held it in 16 quarters. The position peaked at $3.74M in Q3 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Arax Advisory Partners reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Arax Advisory Partners sold 635 Synovus shares in Q1 2026, an estimated $31.8K.
  • Arax Advisory Partners first reported a position in Synovus in Q3 2021 and held it in 16 quarters.
  • Arax Advisory Partners's Synovus position peaked at $3.74M in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.